
Tandem Diabetes Care TNDM
$ 18.16
-2.52%
Annual report 2025
added 02-19-2026
Tandem Diabetes Care Accounts Receivables 2011-2026 | TNDM
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Tandem Diabetes Care
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 165 M | 115 M | 106 M | 115 M | 111 M | 82.2 M | 46.6 M | 35.2 M | 20.8 M | 11.2 M | 14.1 M | 7.65 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 165 M | 7.65 M | 69.1 M |
Quarterly Accounts Receivables Tandem Diabetes Care
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126 M | 128 M | 127 M | 115 M | 107 M | 98.1 M | 93 M | 106 M | 100 M | 98.7 M | 91.4 M | 115 M | 113 M | - | 94.1 M | 111 M | 87.5 M | 80.2 M | 73.7 M | 82.2 M | 82.2 M | 82.2 M | 82.2 M | 46.6 M | 46.6 M | 46.6 M | 33 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 20.8 M | 20.8 M | 20.8 M | 20.8 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 7.65 M | 7.65 M | 7.65 M | 7.65 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 128 M | 5.3 M | 54.8 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | ||
|
Helius Medical Technologies
HSDT
|
117 K | $ 1.98 | -4.81 % | $ 1.2 M | ||
|
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | ||
|
Electromed
ELMD
|
24.7 M | $ 25.1 | -2.49 % | $ 212 M | ||
|
AdaptHealth Corp.
AHCO
|
371 M | $ 13.08 | -2.24 % | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | ||
|
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | ||
|
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | ||
|
Pulmonx Corporation
LUNG
|
12.1 M | $ 1.2 | -2.04 % | $ 48.8 M | ||
|
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | ||
|
Orthofix Medical
OFIX
|
136 M | $ 11.49 | -3.53 % | $ 455 M | ||
|
EDAP TMS S.A.
EDAP
|
18.6 M | $ 3.36 | 1.66 % | $ 126 M | ||
|
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | ||
|
Insulet Corporation
PODD
|
161 M | $ 160.02 | -12.5 % | $ 11.3 B | ||
|
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.64 | 5.95 % | $ 39.8 M | ||
|
ClearPoint Neuro
CLPT
|
6.55 M | $ 10.34 | -6.68 % | $ 293 M | ||
|
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | ||
|
Globus Medical
GMED
|
679 M | $ 87.79 | -3.25 % | $ 11.9 B | ||
|
Sintx Technologies
SINT
|
178 K | $ 1.99 | -7.44 % | $ 5.52 M | ||
|
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | ||
|
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
595 K | - | -0.57 % | $ 7.12 M | ||
|
TELA Bio
TELA
|
10.3 M | $ 0.86 | 10.26 % | $ 40.4 M | ||
|
Butterfly Network
BFLY
|
20.8 M | $ 4.92 | -4.47 % | $ 1.04 B | ||
|
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 14.64 | -3.3 % | $ 343 M | ||
|
Delcath Systems
DCTH
|
11.7 M | $ 10.21 | -3.22 % | $ 366 M | ||
|
IRIDEX Corporation
IRIX
|
7.61 M | $ 1.03 | -0.96 % | $ 17.4 M | ||
|
CONMED Corporation
CNMD
|
248 M | $ 35.96 | -2.26 % | $ 1.12 B | ||
|
LivaNova PLC
LIVN
|
216 M | $ 58.92 | -3.87 % | $ 3.21 B | ||
|
Inspire Medical Systems
INSP
|
120 M | $ 53.41 | -3.08 % | $ 1.57 B | ||
|
LENSAR
LNSR
|
6.38 M | $ 5.39 | 0.75 % | $ 64.5 M | ||
|
Integer Holdings Corporation
ITGR
|
346 M | $ 83.67 | -1.15 % | $ 2.91 B | ||
|
Invacare Corporation
IVC
|
88 M | - | - | $ 24.7 M | ||
|
Varex Imaging Corporation
VREX
|
157 M | $ 11.03 | -8.62 % | $ 457 M | ||
|
Edwards Lifesciences Corporation
EW
|
660 M | $ 81.22 | -1.29 % | $ 47.5 B | ||
|
Tactile Systems Technology
TCMD
|
43.9 M | $ 22.5 | -4.54 % | $ 515 M |